The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3
Open Access
- 1 March 2000
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 72 (3) , 1327-1330
- https://doi.org/10.1046/j.1471-4159.2000.0721327.x
Abstract
: Valproic acid (VPA) is a potent broad‐spectrum anti‐epileptic with demonstrated efficacy in the treatment of bipolar affective disorder. It has previously been demonstrated that both VPA ...Keywords
This publication has 23 references indexed in Scilit:
- Establishment of the Dorso-ventral Axis in Xenopus Embryos Is Presaged by Early Asymmetries in β-Catenin That Are Modulated by the Wnt Signaling PathwayThe Journal of cell biology, 1997
- Increase in AP-1 Transcription Factor DNA Binding Activity by Valproic AcidPublished by Springer Nature ,1997
- Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cellsCurrent Biology, 1996
- A molecular mechanism for the effect of lithium on development.Proceedings of the National Academy of Sciences, 1996
- The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3.Genes & Development, 1996
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995
- Signal Transduction PathwaysArchives of General Psychiatry, 1995
- Efficacy of Divalproex vs Lithium and Placebo in the Treatment of ManiaJAMA, 1994
- Lithium and brain signal transduction systemsBiochemical Pharmacology, 1994
- Chronic Administration of Lithium or Other Antidepressants Increases Levels of DARPP-32 in Rat Frontal CortexJournal of Neurochemistry, 1992